CCZ1
gene geneOn this page
Also known as CGI-43CCZ1A
Summary
CCZ1 (CCZ1 vacuolar protein trafficking and biogenesis associated, HGNC:21691) is a protein-coding gene on chromosome 7p22.1, encoding Vacuolar fusion protein CCZ1 homolog (P86791). Acts in concert with MON1A, as a guanine exchange factor (GEF) for RAB7, promotes the exchange of GDP to GTP, converting it from an inactive GDP-bound form into an active GTP-bound form.
Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in vesicle-mediated transport. Located in intracellular membrane-bounded organelle. Part of Mon1-Ccz1 complex.
Source: NCBI Gene 51622 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 136 total — 2 pathogenic
- MANE Select transcript:
NM_015622
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21691 |
| Approved symbol | CCZ1 |
| Name | CCZ1 vacuolar protein trafficking and biogenesis associated |
| Location | 7p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-43, CCZ1A |
| Ensembl gene | ENSG00000122674 |
| Ensembl biotype | protein_coding |
| OMIM | 620660 |
| Entrez | 51622 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 21 protein_coding, 4 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000325974, ENST00000461592, ENST00000474507, ENST00000478672, ENST00000483394, ENST00000496860, ENST00000628813, ENST00000887568, ENST00000887569, ENST00000887570, ENST00000887571, ENST00000887572, ENST00000887573, ENST00000928073, ENST00000928074, ENST00000928075, ENST00000928076, ENST00000928077, ENST00000928078, ENST00000928079, ENST00000928080, ENST00000928081, ENST00000928082, ENST00000928083, ENST00000971175, ENST00000971176
RefSeq mRNA: 1 — MANE Select: NM_015622
NM_015622
CCDS: CCDS34597
Canonical transcript exons
ENST00000325974 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001614698 | 5900473 | 5900566 |
| ENSE00001626657 | 5910035 | 5910116 |
| ENSE00001639155 | 5918867 | 5918900 |
| ENSE00001700559 | 5911861 | 5911922 |
| ENSE00001752315 | 5912843 | 5912954 |
| ENSE00001789590 | 5902661 | 5902744 |
| ENSE00001802981 | 5919849 | 5919966 |
| ENSE00001905098 | 5925632 | 5926550 |
| ENSE00001942643 | 5898733 | 5898919 |
| ENSE00003538155 | 5901657 | 5901704 |
| ENSE00003592158 | 5923387 | 5923545 |
| ENSE00003615458 | 5900284 | 5900381 |
| ENSE00003617807 | 5923835 | 5923962 |
| ENSE00003681098 | 5900855 | 5900932 |
| ENSE00003682262 | 5905094 | 5905269 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.5893 / max 66.4794, expressed in 1768 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 77128 | 3.9449 | 1677 |
| 77129 | 3.6443 | 1656 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 96.64 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.61 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.44 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.13 | gold quality |
| adrenal gland | UBERON:0002369 | 94.85 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.62 | gold quality |
| Ammon’s horn | UBERON:0001954 | 94.39 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.26 | gold quality |
| substantia nigra | UBERON:0002038 | 94.17 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.16 | gold quality |
| amygdala | UBERON:0001876 | 94.13 | gold quality |
| temporal lobe | UBERON:0001871 | 94.05 | gold quality |
| hypothalamus | UBERON:0001898 | 93.89 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.86 | gold quality |
| left uterine tube | UBERON:0001303 | 93.71 | gold quality |
| primary visual cortex | UBERON:0002436 | 93.61 | gold quality |
| pituitary gland | UBERON:0000007 | 93.48 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.45 | gold quality |
| spleen | UBERON:0002106 | 93.35 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.28 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.16 | gold quality |
| cortical plate | UBERON:0005343 | 93.16 | gold quality |
| putamen | UBERON:0001874 | 93.12 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.10 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.10 | gold quality |
| endocervix | UBERON:0000458 | 93.09 | gold quality |
| esophagus | UBERON:0001043 | 93.01 | gold quality |
| cerebellum | UBERON:0002037 | 93.00 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.43 |
| E-MTAB-6142 | no | 29.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting CCZ1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-4291 | 99.20 | 68.88 | 2969 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
| HSA-MIR-513B-3P | 98.76 | 68.12 | 1577 |
| HSA-MIR-6808-3P | 94.13 | 65.24 | 516 |
Literature-anchored findings (GeneRIF, showing 3)
- The CCZ1 gene is a member of the class B VPS (vacuolar protein sorting) genes and it is engaged in the last stage of delivery of multiple kinds of cargo to the yeast vacuole. (PMID:20709422)
- Authors identified C18orf8/RMC1 as a new subunit of the CCZ1-MON1 RAB7 guanine exchange factor (GEF) that positively regulates RAB7 recruitment to LE/autophagosomes. (PMID:29038162)
- Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections. (PMID:37880247)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccz1 | ENSDARG00000056559 |
| mus_musculus | Ccz1 | ENSMUSG00000029617 |
| rattus_norvegicus | Ccz1 | ENSRNOG00000001032 |
| drosophila_melanogaster | Ccz1 | FBGN0035470 |
| caenorhabditis_elegans | WBGENE00010283 |
Paralogs (1): CCZ1B (ENSG00000146574)
Protein
Protein identifiers
Vacuolar fusion protein CCZ1 homolog — P86791 (reviewed: P86791)
All UniProt accessions (2): P86791, F8WD66
UniProt curated annotations — full annotation on UniProt →
Function. Acts in concert with MON1A, as a guanine exchange factor (GEF) for RAB7, promotes the exchange of GDP to GTP, converting it from an inactive GDP-bound form into an active GTP-bound form.
Subunit / interactions. Interacts with MON1A. Found in a complex with RMC1, CCZ1, MON1A and MON1B.
Subcellular location. Lysosome membrane.
Similarity. Belongs to the CCZ1 family.
RefSeq proteins (1): NP_056437* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013176 | Ccz1 | Family |
| IPR043987 | CCZ1/INTU/HSP4_longin_1 | Domain |
| IPR043988 | CCZ1/INTU_longin_2 | Domain |
| IPR043989 | CCZ1/INTU/HSP4_longin_3 | Domain |
Pfam: PF19031, PF19032, PF19033
UniProt features (9 total): sequence conflict 4, modified residue 3, initiator methionine 1, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9L0D | ELECTRON MICROSCOPY | 3.41 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P86791-F1 | 89.12 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 2, 76, 266
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-9007101 | Rab regulation of trafficking |
MSigDB gene sets: 82 (showing top):
BORCZUK_MALIGNANT_MESOTHELIOMA_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, AAGCAAT_MIR137, TSENG_IRS1_TARGETS_UP, KAAB_FAILED_HEART_ATRIUM_DN, GOCC_VACUOLAR_MEMBRANE, THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, chr7p22, BLALOCK_ALZHEIMERS_DISEASE_UP, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP, DOUGLAS_BMI1_TARGETS_DN
GO Biological Process (1): vesicle-mediated transport (GO:0016192)
GO Molecular Function (2): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515)
GO Cellular Component (5): lysosomal membrane (GO:0005765), cytosol (GO:0005829), Mon1-Ccz1 complex (GO:0035658), lysosome (GO:0005764), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Rab regulation of trafficking | 1 |
| Vesicle-mediated transport | 1 |
| Membrane Trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| transport | 1 |
| cellular process | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| cytoplasm | 1 |
| late endosome | 1 |
| guanyl-nucleotide exchange factor complex | 1 |
| lytic vacuole | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RMC1 | CCZ1 | psi-mi:“MI:0914”(association) | 0.600 |
| RAB7A | CCZ1 | psi-mi:“MI:0914”(association) | 0.590 |
| MON1A | CCZ1 | psi-mi:“MI:0915”(physical association) | 0.590 |
| MON1A | CCZ1 | psi-mi:“MI:0914”(association) | 0.590 |
| CCZ1 | RAB7A | psi-mi:“MI:2252”(guanine nucleotide exchange factor reaction) | 0.590 |
| RMC1 | ANXA2P2 | psi-mi:“MI:0914”(association) | 0.350 |
| RMC1 | ARID1A | psi-mi:“MI:0914”(association) | 0.350 |
| MON1B | CCZ1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCZ1 | MON1B | psi-mi:“MI:0914”(association) | 0.350 |
| CCZ1B | PRPF40A | psi-mi:“MI:0914”(association) | 0.350 |
| CCZ1 | CCZ1B | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (109): CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1B (Proximity Label-MS), CCZ1B (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), CCZ1 (Affinity Capture-MS)
ESM2 similar proteins: A0JMA8, A0JPP5, A1A535, A1A5P5, F1S5L4, O70481, P86790, P86791, P97564, Q008S8, Q0VA04, Q0VD30, Q14D04, Q16K67, Q19317, Q28HU2, Q2KI89, Q3KQ18, Q45GW3, Q4R6I5, Q4S4I5, Q5GJ77, Q5PQS3, Q5R629, Q5R6E9, Q5RD58, Q5SWX8, Q5U245, Q5XIR8, Q5ZKK3, Q5ZLN2, Q61586, Q6NU25, Q6PA97, Q7Z3E5, Q803R2, Q86VS3, Q8C1Y8, Q8CDK3, Q8IWV7
Diamond homologs: A7RJI7, P86790, P86791, Q0VD30, Q28HU2, Q4S4I5, Q54IQ5, Q5ZLN2, Q7T102, Q803R2, Q8C1Y8, Q9VZL5
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CCZ1 | “form complex” | “MON1-CCZ1 guanyl-nucleotide exchange factor complex, MON1B variant” | binding |
| CCZ1 | “form complex” | “MON1-CCZ1 guanyl-nucleotide exchange factor complex, MON1A variant” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
136 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 94 |
| Likely benign | 8 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2423253 | NC_000007.13:g.(?5834270)(6018235_?)del | Pathogenic |
| 3245662 | NC_000007.13:g.(?5900029)(6018317_?)del | Pathogenic |
SpliceAI
2206 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:5898916:ACAGG:A | donor_loss | 1.0000 |
| 7:5898919:GGT:G | donor_loss | 1.0000 |
| 7:5898920:G:GC | donor_loss | 1.0000 |
| 7:5898921:T:G | donor_loss | 1.0000 |
| 7:5900275:AT:A | acceptor_gain | 1.0000 |
| 7:5900276:T:G | acceptor_gain | 1.0000 |
| 7:5900278:TTTCA:T | acceptor_loss | 1.0000 |
| 7:5900279:TTCA:T | acceptor_loss | 1.0000 |
| 7:5900280:TCA:T | acceptor_loss | 1.0000 |
| 7:5900281:CAG:C | acceptor_loss | 1.0000 |
| 7:5900283:G:T | acceptor_loss | 1.0000 |
| 7:5900377:ACAAG:A | donor_loss | 1.0000 |
| 7:5900378:CAAG:C | donor_loss | 1.0000 |
| 7:5900379:AAGG:A | donor_loss | 1.0000 |
| 7:5900380:AGGT:A | donor_loss | 1.0000 |
| 7:5900382:GTAAT:G | donor_loss | 1.0000 |
| 7:5900383:T:A | donor_loss | 1.0000 |
| 7:5900582:GT:G | donor_gain | 1.0000 |
| 7:5900850:TGTAG:T | acceptor_loss | 1.0000 |
| 7:5900852:TA:T | acceptor_loss | 1.0000 |
| 7:5900854:GGTT:G | acceptor_gain | 1.0000 |
| 7:5900926:GTT:G | donor_gain | 1.0000 |
| 7:5900933:G:GG | donor_gain | 1.0000 |
| 7:5901654:CAG:C | acceptor_loss | 1.0000 |
| 7:5901703:AGGTA:A | donor_loss | 1.0000 |
| 7:5901706:T:A | donor_loss | 1.0000 |
| 7:5902651:A:AG | acceptor_gain | 1.0000 |
| 7:5902657:CTAGC:C | acceptor_loss | 1.0000 |
| 7:5902659:A:AG | acceptor_gain | 1.0000 |
| 7:5902659:A:C | acceptor_loss | 1.0000 |
AlphaMissense
3254 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000051403 (7:5901100 G>A), RS1000495260 (7:5898832 G>A,C,T), RS1000511075 (7:5907572 T>A), RS1000670916 (7:5915026 A>G), RS1000747338 (7:5907023 A>C,G), RS1000803330 (7:5914499 G>C), RS1001010513 (7:5907350 A>T), RS1001121503 (7:5899378 T>C,G), RS1001360894 (7:5924020 G>A), RS1001454224 (7:5923288 G>T), RS1001673138 (7:5902279 C>A,G,T), RS1002195467 (7:5900780 A>C,G,T), RS1002304821 (7:5909134 A>G), RS1002363246 (7:5918608 T>C,G), RS1002808246 (7:5908671 C>T)
Disease associations
OMIM: gene MIM:620660 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | increases phosphorylation | 1 |
| Cocaine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Crack Cocaine | increases expression | 1 |
| Gold Compounds | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.